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Abstract
Genome-wide eQTL mapping explores the relationship between gene expression
values and DNA variants to understand genetic causes of human disease. Due to the
large number of genes and DNA variants that need to be assessed simultaneously,
current methods for eQTL mapping often suffer from low detection power, especially
for identifying trans-eQTLs. In this paper, we propose a new method that utilizes
advanced techniques in large-scale signal detection to pursue the structure of eQTL
data and improve the power for eQTL mapping. The new method greatly reduces the
burden of joint modeling by developing a new ranking and screening strategy based
on the higher criticism statistic. Numerical results in simulation studies demonstrate
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the superior performance of our method in detecting true eQTLs with reduced com-
putational expense. The proposed method is also evaluated in HapMap eQTL data
analysis and the results are compared to a database of known eQTLs.
Key Words: Dimension reduction; HC-LORS; Hotspot; Multivariate response; Penalized
regression.
1 Introduction
Expression quantitative trait loci (eQTLs) are genomic regions that carry DNA sequence
variants that influence gene expression (Albert and Kruglyak, 2015). eQTLs act either in
cis, if the SNP is located near the gene whose expression is influenced, or in trans, if the SNP
is located further away from the gene (Chen et al., 2009; Cookson et al., 2009). trans-eQTLs
are particularly challenging to identify in human population studies because of their weak
effects (Westra et al., 2013).
Genome-wide eQTL mapping, first proposed by Jansen and Nap in 2001, explores the
relationship between gene expression levels and DNA variants, including single nucleotide
polymorphisms (SNPs), copy number variants (CNVs), and short tandem repeats and sin-
gle amino acid repeats (Cookson et al., 2009). The goal of eQTL mapping is to identify
genetic variants, usually SNPs, that are significantly associated with the expression of genes
(Shabalin, 2012). Figure 1 shows an example of eQTL results from Wolen and Miles (2012).
In this figure, each dot denotes an identified significant association between a gene and a
SNP. The results reveal that the expression of a gene can be associated with multiple SNPs,
suggesting there exist potential joint effects of multiple SNPs on the expression value of a
gene. In addition, some SNPs are strongly associated with a few genes, (e.g., red dots), and
in this paper, we refer to them as strong-sparse eQTLs. Some are moderately associated
with a number of genes, (e.g., a SNP with multiple blue dots), and we refer to them as
hotspot eQTLs or weak-dense eQTLs.
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Figure 1: An example of eQTLs from Wolen and Miles (2012)
eQTL mapping plays a pivotal role in human disease research, and can help to elucidate
underlying genetic mechanisms of diseases (Cookson et al., 2009; Nica and Dermitzakis,
2013). Many links between genetic markers, such as SNPs, and diseases have been found
through genome-wide association studies (GWAS). eQTL mapping provides a link to under-
stand how SNPs actually influence diseases; when SNPs are associated with the expression
of a gene in eQTL mapping and with a disease in GWAS, this may imply that the expression
of the gene mediates the SNP effect on the disease (Albert and Kruglyak, 2015). eQTL
mapping has helped to elucidate the connection between SNPs and diseases such as Type 1
diabetes, ulcerative colitis, Chron’s disease, and many autoimmune diseases, especially when
SNPs are in non-coding regions (Albert and Kruglyak, 2015).
In traditional eQTL analysis, the SNP effect on gene expression is assessed marginally,
i.e. one SNP-gene pair at a time, which leads to a large number of tests (Shabalin, 2012).
The significant gene-SNP pairs are identified by controlling type I error rates, for example,
the family-wise error rate or the false discovery rate (Benjamini and Hochberg, 1995). This
marginal strategy has the advantage of being computationally efficient and easy to apply.
However, marginal eQTL selection has two primary drawbacks: (1) The total number of
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marginal tests, i.e., the number of SNPs times the number of genes, is large and multiplicity
adjustment tends to result in a conservative finding, especially for identifying trans-eQTLs
and eQTL hotspots. (2) Marginal selection overlooks the potential joint effect of SNPs on
gene expression and cannot account for the non-genetic effects. Ignoring these two features
may not precisely capture the underlying SNP-expression relationship and lead to a loss of
power. These flaws of marginal eQTL selection have motivated the consideration of joint
modeling methods that explore the relationship of gene expression and SNPs simultaneously.
There are many joint modeling methods available for eQTL analysis (Fusi et al., 2012;
Kendziorski et al., 2006; Listgarten et al., 2010; Yang et al., 2013). However, without first
performing screening to reduce the number of SNPs, joint modeling is often computationally
infeasible (Yang et al., 2013). For example, the authors of LMM-EH (Listgarten et al., 2010),
an earlier method performing joint modeling while accounting for hidden factors, reported
that an analysis of a mice dataset required 10 hours to complete even when parallelized
across 1,100 processors. LORS (Yang et al., 2013), another popular joint modeling method
that accounts for hidden factors, requires O(qn2 + n2pq) operations to run, where n is the
sample size, q is the number of genes, and p is the number of SNPs. Since human datasets
often have O(104) genes and O(106) SNPs, LORS is computationally very expensive for
genome-wide eQTL mapping in human datasets. In order to make joint modeling feasible
for large datasets, screening methods can be used to reduce the number of SNPs.
Since only a fraction of SNPs influence gene expression, an optimal screening method
will remove the unimportant SNPs, i.e., SNPs not associated with expression, while keeping
the important SNPs. The results of the screening greatly impact the joint modeling. If the
screening method is not powerful enough, weak eQTLs may be lost too early and not have
a chance to be detected with joint modeling. On the other hand, if the number of SNPs
removed by screening is too conservative, there may be too many SNPs for joint modeling to
be computationally feasible. There is a great need for a screening method that is powerful
enough to keep weak eQTLs but still reduce the number of SNPs enough so that the overall
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computation complexity is reasonable.
A classic example of screening is to use linear regression to model the marginal relation-
ship between each SNP-gene pair, record the p-value of the regression coefficient, and select
those SNPs that have at least one p-values less than a pre-specified threshold (de Oliveira
et al., 2014). The SNPs selected are used in further analysis such as joint modeling. This
classical method and other similar screening methods that select those SNPs associated with
at least one genes have three main flaws: (1) The threshold for marginal p-values is often
chosen arbitrarily or by convention; (2) these methods generally struggle to identify weak
effects of trans-eQTLs; and (3) the existing screening criteria cannot directly indicate the
computation complexity of the follow-up joint modeling. Additionally, these methods have a
tendency to carry over a large number of SNPs that do not actually influence gene expression
into joint modeling, which affects the efficiency of joint modeling.
In this paper, we propose a new ranking and screening strategy to largely reduce the
number of SNPs before joint modeling while retaining both strong and weak eQTLs. Instead
of ranking SNP-gene pairs, we propose to rank only SNPs utilizing the Higher Criticism
(HC) statistic that summarizes the association of the SNP to all genes. The HC statistic has
been developed in high-dimensional statistics for simultaneous detection of sparse and dense
signals (Donoho and Jin, 2004; Cai et al., 2011). In eQTL mapping, an important SNP may
be strongly associated with a few genes (strong-sparse) or weakly associated with a number
of genes (weak-dense). Ranking the SNPs by their HC statistics favors both strong-sparse
and weak-dense SNPs over noise SNPs.
Consequently, a screening procedure can be built upon the HC ranking to efficiently retain
strong-sparse and weak-dense SNPs for joint modeling. We suggest to restrict the number
of SNPs that are allowed to be carried over to joint modeling to the sample size n, so that
joint modeling can be performed effectively with adequate sample size. Comparing to the
existing screening methods that select the top-ranked SNP-gene pairs, our method directly
controls the total number of SNPs carried over to joint modeling while effectively retains
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strong-sparse and weak-dense eQTLs, and greatly reduces the computation complexity.
After HC ranking and screening, many joint modeling methods can be applied to gene
expression data and the reduced subset of SNPs. We outline our methodology in detail
in Section 2 and provide an overview of a candidate joint modeling method that can be
used after screening. Following this, we perform a simulation study to demonstrate the
finite-sample performance of our method, and apply our method to eQTL data from the
International HapMap Project.
2 Methodology
2.1 Initial Estimate
The first step of our method is to construct an initial estimate Bˆp×q, where p and q are
the numbers of SNPs and genes, respectively. The initial estimate can be obtained by the
marginal regression method introduced in Yang et al. (2013) that solves the optimization
problem
min(βi,µ,L)
1
2
‖Y−Xiβi − 1µ− L‖2F + λ‖L‖∗, (2.1)
where Y ∈ Rn×q is a matrix of gene expression levels, Xi ∈ Rn×1 is the vector of genotypes
of the ith SNP, βi ∈ R1×q is a row vector of coefficients corresponding to the association of
the ith SNP to all the q genes, µ ∈ R1×q is a row vector of intercepts, L ∈ Rn×q is a matrix
of non-genetic factors that influence gene expression, and ‖L‖∗ is the nuclear norm of L.
The optimization problem in equation (2.1) provides a mechanism for handling hidden, non-
genetic factors that influence gene expression. Accounting for these hidden, unobservable
factors has been shown to lead to better eQTL mapping performance (Fusi et al., 2012;
Listgarten et al., 2010; Yang et al., 2013). The algorithm to solve (2.1) is presented in the
appendix. Denote the estimate for the coefficients of the ith SNP as βˆi ∈ R1×q for i = 1, . . . , p.
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We stack these p row vectors to form the initial estimate Bˆp×q.
2.2 Summary Statistic for each SNP using Higher Criticism
The next phase of our methodology is to rank each SNP by its importance to the gene
expression levels. We propose to use the higher criticism (HC) statistic to measure the
importance of each SNP because the HC statistic has a desirable property of being sensitive
to both sparse and dense signals (Cai et al., 2011).
In order to construct the HC statistic, the initial estimate Bˆp×q must be standardized.
Let Zij be the standardized βˆij corresponding to the i
th SNP and the jth gene. We calculate
the standardized estimates Zij as
Zij =
βˆij√
(XTi Xi)
−1Vˆ (Yj −Xiβˆij)
, (2.2)
where Vˆ (Yj −Xiβˆij) denotes the sample variance of Yj −Xiβˆij.
For a given SNP, the null hypothesis is that the SNP is not associated with any genes. The
alternative hypothesis is that the SNP is associated with at least one gene. The hypotheses
for all SNPs can be formulated as follows for i = 1, . . . , p,
H0i : Zij ∼ N(0, 1), j = 1, . . . , q,
H1i : Zij ∼ (1− ηi)N(0, 1) + ηiN(µi, σ2i ), j = 1, . . . , q,
(2.3)
where ηi ∈ [0, 1] denotes the proportion of genes regulated by SNP i; µi (6= 0) and σ2i (> 0)
are the mean and variance of Zij, respectively, if SNP i is associated with gene j. All of the
parameters ηi, µi, and σi are unknown and varying with i.
In reality, most SNPs are not truly associated with any genes; therefore most of the null
hypotheses H0i, i = 1, . . . , p, are true. The alternative hypotheses describe the distribution of
Zij for important SNPs by mixture models. Such mixture models include the strong-sparse
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case (µi is relatively large and ηi is small) and the weak-dense case (µi is small and ηi is
relatively large).
Donoho and Jin (2004) developed the HC statistic to test the existence of sparse sig-
nals among a large number of observations. In this paper, we propose to use the HC
statistic to summarize the importance of each SNP in regulating the genes. We present
an analogous version of the HC statistic based on the standardized test statistic Zij. Let
Si(t) =
∑q
j=1 I{|Zij| ≥ t}. The HC statistic of SNP i is calculated as
HCi = sup
t≥0
{√
q
Si(t)/q − Φ¯(t)√
Φ¯(t)(1− Φ¯(t))
}
.
Note that under the null hypotheses in equation (2.3), the expectation and variance of
Si(t)/q are
E(Si(t)/q) = Φ¯(t); V (Si(t)/q) =
Φ¯(t)(1− Φ¯(t))
q
,
where Φ¯(t) = P (N(0, 1) > t). Therefore large values of HCi suggest that SNP i is important
in regulating the genes. More specifically, when SNP i is important (H1i is true), Zij has
non-zero mean value for some j, which causes elevated mean of Si(t) for some t. Consider
the case that SNP i is strong-sparse, we observe several large Zij, and the standardized
Si(t) may reach its max at a large t. On the other hand, when SNP i is weak-dense, the
standardized Si(t) may reach its max at a moderate t. By taking the maximum over t, the
HC statistic can capture the information for both strong-sparse and weak-dense SNPs.
2.3 HC Ranking and Screening
After the HC statistics are calculated for all SNPs, we propose to rank the SNPs by their
HC statistics in a decreasing order. Since ranking SNPs by their HC statistics tends to
place strong-sparse and weak-dense SNPs before irrelevant SNPs, we can select only the
top-ranked SNPs for joint modeling. We may select the top n ranked SNPs, where n is the
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sample size, so that the ratio of sample size to dimensionality is adequate for joint modeling.
Similar screening criterion has been used in Yang et al. (2013). However, Yang et al. (2013)
does not rank SNPs by a summary statistic; they rank and keep the top n SNPs by the
initial estimate Bˆ for each gene. The SNPs entering joint modeling are the union of the
SNPs selected for each gene. Compared to Yang et al. (2013), our ranking and screening
strategy can be more efficient in selecting much less SNPs for joint modeling while retaining
both strong-sparse and weak-dense SNPs.
2.4 Joint Modeling after SNP Screening
Let Xr ∈ Rn×n represent the reduced SNP matrix corresponding to the n SNPs selected
by the HC ranking and screening. A joint modeling method can be used to explore the
relationship between the gene expression matrix Y and Xr. A popular method is LOw-
Rank representation to account for confounding factors and make use of Sparse regression
for eQTL mapping (LORS) (Yang et al., 2013), the model structure for which is
Y = 1µ+ XrBr + L + e,
where Y ∈ Rn×q is the matrix of gene expression levels, Xr ∈ Rn×n is the reduced matrix
of SNPs, B ∈ Rn×q is a matrix of coefficients, L ∈ Rn×q is a matrix of non-genetic factors,
1 ∈ Rn×1 is a vector of ones, µ ∈ R1×q is a row vector of intercepts, and e ∈ Rn×q is an
error matrix with eij ∼ N(0, σ2). It is assumed that there are only a few hidden, non-
genetic factors that influence gene expression and that there are only a small fraction of true
SNP-gene associations. In other words, L is low-rank and Br is sparse.
In Lagrangian form, the LORS optimization problem is
minB,µ,L||Y−XrBr − 1µ− L||2F + ρ||Br||1 + λ||L||∗, (2.4)
where ρ enforces the sparsity constraint on Br and λ enforces the low-rank constraint on
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L. The LORS MATLAB implementation is freely available at http://zhaocenter.org/
software/. We also implemented LORS algorithm in R, which is available upon requests
from the authors.
Besides LORS, there are other methods that can be applied at the joint modeling stage,
giving the users freedom to select the method that best suits their needs; for example List-
garten et al. (2010); Fusi et al. (2012); Velu and Reinsel (2013); Gao et al. (2014); Ju al.
(2017); etc.
3 Simulation Study
In this section, we perform simulation studies to demonstrate the efficiency of HC ranking
and compare HC ranking with other popular ranking methods. The SNPs selected by HC
ranking and screening are carried over to joint modeling. We compare the whole procedure
with the marginal screening and joint modeling procedure in Yang et al. (2013).
3.1 Simulation Setup
Genotype data were obtained from HapMap3, the third phase of the International HapMap
Project. We focus on the data of chromosome 1, which includes 24806 SNPs for 160 subjects
after LD pruning. Details of the data are provided in Section 4 (eQTL Data Analysis). We
simulate expression data of 200 genes for the 160 subjects.
The setup of the simulation study is similar to the design of the simulation study in the
original LORS paper (Yang et al., 2013). Let B ∈ R24806×200 be the coefficient matrix of
SNP effects and let U ∈ R160×200 be a matrix of non-genetic factors. Since we assume that
B is sparse, only 20 SNPs were set to be active, and for each active SNP, m = 10 or m = 50
genes were randomly selected to be influenced. We set β to be either 0.5 or 2. The case
where β = 2 and m = 10 represents the strong-sparse scenario and the case where β = 0.5
and m = 50 represents the weak-dense scenario.
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It is known that hidden, non-genetic factors influence gene expression (Fusi et al., 2012;
Ju al., 2017; Listgarten et al., 2010; Yang et al., 2013). We simulate a matrix of hidden
factors U through the following steps: (1) Hn×k ∼ N(0, I) where k is the number of hidden
factors and is set to 10; (2) Σn×n = HHT ; (3) Uj ∼ N(0, 0.1 × Σ), where Uj is the jth
column of U. Finally, Y was simulated by
Y = XB + U + e,
where e has its jth column simulated by ej ∼ N(0, I).
3.2 Effectiveness of Ranking SNPs by HC Statistic
First, we evaluate the effectiveness of the HC ranking. It is critical that an effective ranking
procedure would rank active SNPs highly. Two baseline methods are used in comparison to
the HC ranking: (1) ranking SNPs by the means of each row of Bˆ and (2) ranking SNPs by
maximum absolute value by row. We refer to these two alternative ranking procedures as
ROWMEANS and EXTREMEVAL respectively. By design, ROWMEANS should be good at
detecting weak-dense SNPs and EXTREMEVAL should be good at detecting strong-sparse
SNPs.
To evaluate the effectiveness of the three ranking methods, we use precision-recall curves.
A precision-recall curve, commonly used in information retrieval, shows the precisions of a
selection rule for different values of recall. The precision and recall are defined as
Precision =
TP
TP + FP
Recall =
TP
TP + FN
,
where TP is the number of true positive SNPs, FP is the number of false positive SNPs,
and FN is the number of false negative SNPs. Recall takes values in {1/20, 2/20, . . . , 20/20}
because there are 20 active SNPs. For a given recall value, we calculate the average precisions
(over 100 simulations) for all three ranking methods and report the results in Figure 2. A
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method with higher precision-recall curve ranks more active SNPs before noise SNPs, relative
to the other methods.
As seen in Figure 2, the HC ranking performs better at detecting and prioritizing active
SNPs over noise SNPs than either the ROWMEANS ranking or EXTREMEVAL ranking in
both strong-sparse and weak-dense settings. The ROWMEANS method performs particu-
larly poorly, with a very low precision for each value of recall. The EXTREVEVAL ranking
is more competitive with the HC ranking in the strong-sparse case, but the HC ranking still
maintains an advantage.
Figure 2: Average precision versus recall for SNP ranking. The left plot illustrates the
strong-sparse case with β = 2,m = 10. The right plot illustrates the weak-dense case
with β = 0.5,m = 50. In the legend, HC represents the higher criticism ranking, RM the
ROWMEANS ranking, and EV the EXTREMEVAL ranking.
3.3 Screening and Joint Modeling
In this section, we compare the performance of our procedure with the marginal screening and
joint modeling procedure in Yang et al. (2013). For fairness of comparison, LORS algorithm
is used for joint modeling in both procedures. We refer to the procedure in Yang et al. (2013)
as MS-LORS and our multi-step procedure as HC-LORS that provides eQTL mapping by
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a) using the algorithm in equation (2.1) to provide an initial estimate; b) standardizing
the estimate and calculating HC statistics; c) ranking SNPs by HC and selecting the top n
SNPs; and d) applying LORS algorithm for joint modeling on the selected SNPs and the
expression matrix. We compare both methods by their success in detecting true eQTLs and
the computation time required to run each method.
Denote the estimates of B from HC-LORS and MS-LORS as BˆHC and BˆMS, respectively.
The entries of BˆHC and BˆMS are ranked by magnitude in descending order. For each BˆHCij
or BˆMSij that is nonzero, if the corresponding true Bij 6= 0 the association is called a true
positive (TP); if Bij = 0, the entry is called a false positive (FP). The precision for the largest
1,000 associations sorted by the estimates of Bij is presented in Figure 3. Higher precision
means a larger proportion of true eQTLs are captured in the selected SNP-gene association
pairs. As seen in Figure 3, HC-LORS performs better than MS-LORS in detecting true
eQTLs and prioritizing them over noise in both strong-sparse and weak-dense scenarios.
Figure 3: Average precision for the top 1,000 associations in strong-sparse (left) and weak-
dense (right) scenarios. In the legend, HC-LORS refers to the proposed multi-step procedure
and MS-LORS refers to the screening and modeling method in Yang et al. (2013).
HC-LORS requires less computational expense than MS-LORS due to effective ranking
and screening. In fact, the screening step of MS-LORS selects 3066 and 3059 SNPs on
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Table 1: Median values of computation time (in seconds) for joint modeling
Setting Method Computation time
strong-sparse (β = 2,m = 10) HC-LORS 509
MS-LORS 1423
weak-dense (β = 0.5,m = 50) HC-LORS 581
MS-LORS 1223
average in the strong-sparse and weak-dense scenarios, respectively, whereas our HC ranking
and screening selects only 160 SNPs in both scenarios. Consequently, the computation time
of HC-LORS for joint modeling is much less than that of MS-LORS. Table 1 summarizes
the median values of the computation times for joint modeling of the two methods from
100 replications. The improvement in computational cost coupled with more accurate eQTL
detection makes HC-LORS a promising method for large scale eQTL analysis.
4 eQTL Data Analysis
We illustrate the utility of HC-LORS on the expression and SNP data from the third phase of
International HapMap Project (HapMap3). The dataset includes 1301 samples from a variety
of human populations. The genotype data are provided on ftp://ftp.ncbi.nlm.nih.gov/
hapmap/genotypes/hapmap3_r3/plink_format/ and the details of gene expression data are
provided on http://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-264/. We focus
on chromosome 1 and use PLINK to remove correlated SNPs via linkage disequilibrium
pruning with a window size 50, a moving window increment of 5 SNPs, and a cutoff value
of r2 = 0.5. Again using PLINK, the pruned genotype data were converted into numerical
SNP data. Following this, the data were set to include only Asian individuals for which there
were gene expression data available. The resulting data have 2010 gene probes and 24806
SNPs for 160 subjects. Although the influence of tuning the parameters λ and ρ in equation
(2.4) should be minor, we address potential issues by using cross validation to select the
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parameters in (2.4) (Xu and Liang, 2001; Yang et al., 2013).
We use the classification method of Westra et al. (2013) to identify eQTLs as cis or trans
(Westra et al., 2013). We call an eQTL cis if the distance between the base pair positions of
the SNP and the probe midpoint is less than 250 kilobases (kb) and call the eQTL trans if
this distance is greater than 5 megabases (mb). The top 5 SNPs, in terms of the estimated
association effects, along with the associated probes are seen in Table 2. A complete list
of identified SNP and probe associations for the two methods, ordered by the estimated
association effects, can be found in the supplemental document.
Table 2: SNPs with the strongest estimated associations and the distance between the SNP
location and probe midpoint. HC-LORS denotes the proposed multi-step procedure; MS-
LORS denotes the screening and modeling method in Yang et al. (2013).
Method SNP (Gene) Probe (Gene) Distance Class.
HC-LORS
rs12745189 (Intergenic) ILMN 1762255 (GSTM1) 45.34 (kb) cis
rs12745189 (Intergenic) ILMN 1668134 (GSTM1) 46.55 (kb) cis
rs4657741 (TIPRL) ILMN 1779432 (TIPRL) 21.53 (kb) cis
rs2138686 (BMP8B) ILMN 1653730 (OXCT2) 7.68 (kb) cis
rs3007708 (Intergenic) ILMN 1796712 (S100A10) 12.23 (kb) cis
MS-LORS
rs2239892 (GSTM1) ILMN 1762255 (GSTM1) 2.38 (kb) cis
rs10802457 (ZNF695) ILMN 1705078 (CHI3L2) 133.63 (mb) trans
rs2239892 (GSTM1) ILMN 1668134 (GSTM1) 1.18 (kb) cis
rs10802457 (ZNF695) ILMN 1685045 (CHI3L2) 133.64 (mb) trans
rs12121466 (Intergenic) ILMN 1769839 (L1TD1) 44.50 (mb) trans
As seen in Table 2, the strongest associations detected by HC-LORS represent cis-eQTLs,
as the distance between the probe midpoint and the SNP position is small, and the strongest
associations detected by MS-LORS are cis and trans-eQTLs. Since trans-eQTLs tend to have
very weak signals, we expect the strongest signals to correspond to cis-eQTLs (Westra et al.,
2013). Both methods detect a large proportion of trans-eQTLs; out of the 158 associations
detected by HC-LORS, 113 of them are classified as potential trans-eQTLs and out of the
117 associations detected by MS-LORS, 106 are classified as trans-eQTLs. This suggests
that both methods show promise in trans-eQTL detection.
In addition to identifying candidate cis and trans-eQTLs, both methods identify SNPs
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associated with multiple genes, or hotspots. Since Yang et al. (2013) define hotspot as a
SNP being associated with the expression of at least 15 genes out of 7084 (or 0.21%), we
define hotspots as cases where a SNP is associated with at least d0.0021× 2010e = 5 genes.
It can be seen in Table 3 that HC-LORS detects four hotspots and MS-LORS detects two
hotspots.
Table 3: SNPs that are declared hotspots by HC-LORS and MS-LORS
Method SNP (Gene) Associated Genes
HC-LORS rs2297663 (LRP8) AIM2 GSTM1 L1TD1 CAMK1G C1orf123
PHGDH SH2D2A
rs12408890 (WDR8) LRRC8C WDR8 GSTM1 L1TD1 FAM79A
GPX7
rs12745189 (Intergenic) GSTM1 GSTM1 GSTM4 GSTM4 HSPA6
rs11204737 (ARNT) CTSS ARNT CGN MNDA PRRX1
MS-LORS rs4926440 (SCCPDH) LRRC8C ATP1B1 IL23R SFN BCAR3 MFSD2
NECAP2 WDR8 RAP1GAP EDG1 PIGR
IBRDC3 CNN3 GSTM1 GSTM1 RALGPS2
ZC3H12A L1TD1 MAP3K6 FLJ20054 IPP
WNT3A C1orf63 CGN NPL ATP1B1 DARC
PADI4 DENND2D FCGR2B VASH2 SCCPDH
LOC645436 ATP2B4 LOC644094 C1orf54
SSR2 LOC391157 HSPA6 LOC729853 NMNAT2
FLJ25476 LPGAT1 TNFSF4
rs2239892 (GSTM1) LRRC8C WDR8 GSTM1 L1TD1 FAM79A GPX7
To further examine the eQTL detection by HC-LORS and MS-LORS, we compare our
findings with the cis and trans identification in the seeQTL database of the University of
North Carolina at Chapel Hill, available at http://www.bios.unc.edu/research/genomic_
software/seeQTL/ (Xia et al., 2011), which report eQTLs identified from a meta-analysis
from HapMap human lymphoblastoid cell lines. We find that out of the 158 SNP-probe
associations detected by HC-LORS, 23 are confirmed by the seeQTL database. On the
other hand, out of the 117 associations detected by MS-LORS, only 3 are confirmed by the
seeQTL database. Figure 4 presents the percentage of identified eQTLs that also appear
in seeQTL database for each method. It is clearly shown that HC-LORS achieves higher
percentage and, therefore, better consistency with the database. This is particularly obvious
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Figure 4: Proportion of identified eQTLs that also appear in seeQTL database. The left
plot presents the proportion for the ranked eQTLs of each method. The right plot zooms
in on the top 25 detected eQTLs of each method. In the legend, HC-LORS and MS-LORS
refer to our multi-step method and the screening and modeling method presented in Yang
et al. (2013), respectively.
when comparing the overlapping percentage of the top 25 ranked eQTLs detected by each
method (right panel of Figure 4). This result further supports the efficiency of our method
in detecting true eQTLs and prioritizing them over noise.
Table 4 summarizes the identified SNPs that are also in seeQTL, the genes that the SNPs
are associated with, and cis/trans classifications. It can be seen that, although both methods
detect many trans-eQTLs, almost all the overlapped eQTLs are cis. This could be due to
the limited record of trans-eQTLs in the database. The proposed study has the potential to
provide timely development for trans detection in eQTL mapping.
5 Discussion
In this paper, we present a new ranking and screening strategy based on the higher criticism
(HC) statistic for eQTL mapping. The HC ranking and screening is effective in prioritizing
and selecting both strong-sparse and weak-dense SNPs over noise SNPs. Combing HC rank-
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Table 4: SNP gene pairs identified by HC-LORS and LORS also found in the UNC seeQTL
database. * denotes that the association was found through HC-LORS or LORS and +
denotes that the association was found in the seeQLT database
Method SNP Associated Gene(s) Classification
HC-LORS
rs10888391 CTSS∗+ cis
rs11204737 CTSS∗+ cis
rs12137269 ST7L∗+ cis
rs12568757 CTSK∗+ cis
rs12745189 GSTM1∗+GSTM4∗+ cis
rs2138686 OXCT2∗+PPIE∗+BMP8B∗+ cis
rs2297663 C1orf123∗+ cis
rs234098 FAM129A∗+ cis
rs3007708 S100A10∗+THEM4∗+ cis
rs4654748 NBPF3∗+ cis
rs4660652 NDUFS5∗+ cis
rs518365 IPP ∗+ cis
rs6684005 EFCAB2∗+ cis
rs954679 ST7L∗+ cis
rs2310752 TGFBR3∗DPYD+ trans
LORS
rs2239892 GSTM1∗+ cis
rs4926440 SCCPDH∗+ cis
ing and screening with joint modeling, our multi-step procedure, HC-LORS, shows higher
accuracy in detecting true eQTLs with lower computation cost compared to existing meth-
ods. In an analysis of eQTL data from the International HapMap Project, the result of
HC-LORS shows higher consistency with the seeQTL database than existing methods.
Due to limited sample size (n = 160), SNPs on chromosome 1 have been included in our
analysis. The proposed method can be applied to genome-wide eQTL mapping with larger
sample size. The emerging technological discoveries will result in more data being available
for eQTL analysis and greater computational challenge. Because of this, an effective screen-
ing method to reduce the number of SNPs will be of even greater importance. Our method
shows promise in detecting cis- and trans-eQTLs and dramatically reducing computational
expense.
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Appendix
Marginal Estimate Algorithm
We obtain the solution of (2.1) using the screening algorithm presented in the supplemental
document of Yang et al. (2013) based on the following Lemma from Mazumder et al. (2010).
Lemma 5.1 Suppose matrix W has rank r. The solution to the optimization problem
minZ‖W − Z‖2F + λ‖Z‖∗ is given by Zˆ = Sλ(W) where Sλ(W) = UDλVT with Dλ =
diag[(d1 − λ)+, ..., (dr − λ)+] and UDVT is the SVD of W
The screening algorithm iteratively solve the follows.
1. Fix (Bi, µ). The optimization problem becomes minL||Y−XiBi−1µ−L||2F +λ||L||∗
• By Lemma 5.1 the solution is L = Sλ(Y−XiBi − 1µ)
2. Fix L. The optimization problem becomes argmin(Bi,µ)
1
2
‖Y− L−XiBi − 1µ‖22
• This problem can be solved by ordinary least squares
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